Abstract: Systems and processes for fluid regulation may provide diagnostic information that is useful for evaluating the condition and/or needed repairs/maintenance for fluid regulation systems. In particular implementations, a system and process for fluid regulation may include the ability to receive a representation of an input signal to an electric-to-pressure converter for facilitating positioning of a fluid regulator component, the electric-to-pressure converter adapted to be part of a fluid regulation system including a fluid regulator and a fluid regulator controller, and to determine at least one fluid regulation system condition based on the converter input signal.

Abstract: A receiver for receiving a broadcast channel comprising a spectrum analyzer physically integrated into the receiver and operative to receive an intermediate frequency signal and process the spectral contents of the receive signal.

Abstract: A system and method for data communication connecting on-line networks with on-line and off-line computers. The present system provides for broadcast of up to the minute notification centric information thereby providing an instant call to action for users who are provided with the ability to instantaneously retrieve further detailed information. The notification centric portions of information is wirelessly broadcast to wireless receiving devices which are attached to computing devices. Upon receipt of the information at the personal computer, the user is notified through different multimedia alerts that there is an incoming message. Wirelessly broadcasted URL's, associated with the data, are embedded in data packets and provide an automated wired or wireless connection back to the information source for obtaining detailed data.

Abstract: A compound of formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1 is H or C1-6alkyl; R2 is wherein defines the point of attachment of the ring; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation of a variety of conditions and diseases.

Abstract: In a fence having a plurality of posts, vertically-spaced rails extend across the posts. Horizontally-spaced union strips are extended across the rails, and sheeted infill material is positioned within the open faces of the union strips, so that the sheeted infill material extends from the first union strip to the second union strip.

Abstract: The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl; R3 is selected from the group consisting of C1-6alkyl, NH2 and R5CONH; R4 is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; and R5 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.

Abstract: The invention provides FabK polypeptides and polynucleotides encoding FabK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing FabK polypeptides to screen for antibacterial compounds.

Abstract: A modular spring support mounting for a sash window spring counterbalance arrangement includes at least a first spring support mounting element and a second spring support mounting element each for supporting a respective coil spring. The first spring support mounting element includes a pair of wedged shaped cross section projections. The second spring support mounting element includes an interengagement fitting which engages the pair of wedged shaped cross section projections to in use securely interconnect the first and second spring support mounting elements together. Also a method of installing such a modular spring mounting includes the step of laterally slidingly engaging the spring mounting elements to securely interlock the elements together.

Abstract: The invention provides FabK polypeptides and polynucleotides encoding FabK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing FabK polypeptides and polynucleotides as diagnostic reagents and in diagnostic assays to screen for microbial infections in organisms and infestations in materials.

Abstract: The invention provides the compounds of formula (I) in which: R1 is selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR4R5)n and B(CR4R5)n; R2 is C1-2alkyl substituted by one to five fluorine atoms; R3 is selected from the group consisting of C1-6alkyl, NH2 and R7CONH; R4 and R5 are independently selected from H or C1-6alkyl; A is an unsubstituted 5- or 6-membered heteroaryl or an unsubstituted 6-membered aryl, or a 5- or 6-membered heteroaryl or a 6-membered aryl substituted by one or more R6; R6 is selected from the group consisting of halogen, C1-6alkyl, C1-6alkyl substituted by one more fluorine atoms, C1-6alkoxy, C1-6alkoxy substituted by one or more F, NH2SO2 and C1-6alkylSO2; B is selected from the group consisting of where defines the point of attachment of the ring; R7 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl

Abstract: Prokayrotic FAB I polypeptides and DNA (RNA) encoding such FAB I and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such FAB I for the treatment of infection, such as bacterial infections. Antagonists against such FAB I and their use as a therapeutic to treat infections, such as staphylococcal infections are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to the presence of FAB I nucleic acid sequences and the polypeptides in a host. Also disclosed are diagnostic assays for detecting polynucleotides encoding FAB I and for detecting the polypeptide in a host.

Abstract: A prevention-based network auditing system includes a central compliance server generating network policies and configuring audits of the data communications network. The compliance server presents a graphical user interface (GUI) to describe the specific data gathering parameters, policies to be analyzed, and the schedule of analysis. One or more audit servers strategically deployed around the network employ heterogeneous data-gathering tools to gather information about the network in response to the configured audits, and transmit the gathered information to the compliance server. An audit repository stores the gathered information for use by the compliance server for security and regulatory policy assessment, network vulnerability analysis, report generation, and security improvement recommendations.

Abstract: An EGR equipped internal combustion engine is controlled to maximize the beneficial effects and minimize the detrimental effects of EGR on engine operation. Specifically, at least one parameter indicative of the O2 concentration in the intake mixture and/or at least one parameter indicative of the H2O concentration in the intake mixture is monitored, and the monitored parameter is relied on to control one or more aspects of engine operation by open loop adjustment of other control strategies and/or by a separate closed loop control strategy. These controls are applicable to virtually any engine, and are particularly beneficial to lean burn engines such as diesel (compression ignition) engines, spark ignited natural gas engines, and dual fuel or other compression ignited natural gas engines. The engine may be equipped with either actively controllable EGR or passive and uncontrolled EGR.

Abstract: A system and method are provided for organizing and loading orthodontic appliances, for example orthodontic brackets, onto set-up trays. The system includes an organizer tray which holds a set-up tray in a fixed orientation, and also holds a plurality of packages of orthodontic brackets in predetermined relationships to bracket staging areas on the set-up tray. Bracket packages and the organizer tray are configured so that the brackets are presented in the same orientation, when in their packages held by the organizer tray, as they will have when transferred to the set-up tray. As a result, the brackets can be loaded onto the set-up tray from the packages without re-orientation. The organizer tray has a storage base that holds supplies of packages of the different brackets of a given set so that the organizer tray can be reloaded with packages. Preferred organizer tray and package configurations are also provided.

Abstract: According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(?O)-aryl or —C(?O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the ? or ? configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; and salts and solvates thereof together with a long-acting ?2-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of COPD over a period of 24 hours or more.

Abstract: A prevention-based network auditing system includes a central compliance server providing a user interface allowing a user to schedule and configure a network audit. The configured audit is stored in an audit repository until its scheduled time. At such a time, the compliance server automatically invokes one or more audit servers to gather information about the network. The compliance server receives the gathered information and electronically applies a network policy to the information for determining compliance with the policy. A remediation task may be generated if the policy has been violated, and the task monitored until its completion.

Abstract: A prevention-based network auditing system includes a central compliance server storing both natural language policy documents and machine-processable policy rules in an audit repository. The compliance server provides a client-side user interface allowing a user to easily generate a machine-auditable policy by selecting/generating a natural language policy source document, and linking the applicable machine-processable policy rules to the applicable portions of the source document. The selected machine-processable policy rules are then applied to information gathered about the network during a scheduled network audit session for efficiently and systematically determining whether policy violations and/or vulnerabilities exist.

Abstract: The invention provides methods for identifying agonists and antagonists of FabK polypeptides.

Abstract: There are provided compound of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents C3-8 cycloalkyl or C3-8 cycloalkenyl either of which may optionally be substituted by one or more groups selected from oxo, methyl, methylene and halogen; R3 represents hydrogen, methyl (which may be in either the &agr; or &bgr; configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and (AA) represents a single or a double bond; and solvates thereof, processes for preparing them and their use in therapy.

Abstract: The invention provides the compounds of formula (I) and pharmaceutically acceptable derivatives thereof, in which: R1 and R2 are independently selected from H, C1-6 alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl or C4-12bridged cycloalkane; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation and a variety of conditions and diseases.